Management Team
 |
Kathy Rowlen, Ph.D.Chief Executive Officer and Co-founderDr. Kathy Rowlen has more than 20 years of management and research experience in business and academics, with more than 10 years in the field of biotechnology. Rowlen was a successful Professor of Chemistry at the University of Colorado in Boulder from 1991 to 2008. After co-founding InDevR in 2003, she transitioned to a full-time position as InDevR’s CEO in 2008. Dr. Rowlen has a well-earned reputation as a resourceful business entrepreneur and has raised more than $11 million in non-dilutive company funding. Committed to taking InDevR to the next level, Rowlen has advanced the business structure of InDevR, creating effective sales, marketing and business development teams. The company is now marketing and selling its first product line, the ViroCyt® Virus Counter®, through a global network of value-added distributors. Under Dr. Rowlen’s leadership, the company received a 2010 “Colorado Companies to Watch” award. |
 |
Laura Kuck, Ph.D.Director of Production and Co-FounderDr. Laura Kuck has more than 15 years of operations management experience, including 10 years in the environmental laboratory sector. Her background includes positions as a Scientific Advisor for the USFDA, Laboratory Director for Onsite Laboratories, Quality Assurance Manager for Dames and Moore, and Laboratory Director for Resna Laboratories. Under Dr. Kuck’s leadership, the company has made significant investments in quality processes. These investments include creation of a customer service department and implementation of a client relationship management system, strict document controls for the production and testing of instruments and consumables, and continued improvements in inventory management. Her commitment to the quality of InDevR products is demonstrated by the 2010 release of the CE compliant ViroCyt 2100 Virus Counter – a major corporate milestone. In addition to developing InDevR’s ampliPHOX technology she is an inventor on two related pending patents for the technology. Dr. Kuck received her B.S. and M.S. degrees from the University of California, Davis and her Ph.D. in chemistry from the University of Colorado, Boulder. |
 |
John Birks, Ph.D.Executive Vice President and Co-founderIn addition to his role at InDevR Inc., Dr. John W. Birks is co-founder and President of 2B Technologies, Inc. in Boulder, Colorado. Under Birks’ leadership, 2B Technologies has sold more than 2,000 instruments for air pollution monitoring worldwide. He is also Professor Emeritus of Chemistry and Biochemistry and Fellow Emeritus of the Cooperative Institute for Research in Environmental Sciences (CIRES) of the University of Colorado at Boulder where he served on the faculty for 25 years. Dr. Birks has published more than 130 scientific papers, edited 3 books, and holds ten U.S. patents. Dr. Birks received his B.S. (high honors) from the University of Arkansas and his M.S. and Ph.D. from the University of California, Berkeley. |
 |
Michael Artinger, Ph.D.Vice President of Commercial OperationsDr. Artinger oversees the commercialization of innovation at InDevR, including sales, marketing, customer support, partnering, production and product development. He provides significant management experience gained from multiple life science verticals and roles at Nanodisc, Keystone Biomedical, Documentum, ActiveCyte, Decision Resources and Genome Therapeutics. Dr. Artinger earned a B.A. in Applied Ecology and a Ph.D. in Biology, both from the University of California, Irvine. He conducted his postdoctoral research at the Cardiovascular Research Center, with joint appointments to Harvard Medical School and Massachusetts General Hospital. He was also a Visiting Scientist in the Genetics Division at Brigham and Women’s Hospital. |
 |
Shannon RodriguezVice President of Finance and AdministrationWith ten years of accounting and finance experience and more than seven years of service to InDevR, Shannon directs the finance department. Under Shannon’s leadership, the company has met all of the challenges of complying with the Federal Acquisition Regulations (FAR) requirements. Shannon has created and manages all procurement and subcontracting procedures, financial and account aspects of cost control systems, compliancy of overhead rate calculations as well as compliance with public laws and regulations. She specializes in financial reporting, forecasting, budgeting, grants management and cost control. She also directs all human resource activities and assists with business planning, as well as mergers and acquisitions. Shannon proudly serves her community as a board member for the GO3 Foundation. Shannon received her B.S. in Business Administration, Operations Management from the University of Colorado, Boulder. |
 |
Erica Dawson, Ph.D.Director of Product DevelopmentAs Director of Product Development, Dr. Dawson received her B.S. (summa cum laude) from Hartwick College in Oneonta, NY and her Ph.D. in Analytical Chemistry from The University of North Carolina at Chapel Hill. |
 |
Craig HoechstetterDirector of Sales & Customer SupportAs the Director of Sales and Customer Support, Craig Hoechstetter is responsible for all sales related activities including developing and executing effective global sales strategies, direct sales to InDevR’s clients, global channel expansion, and management and supervision of the customer support and technical support teams. Prior to joining InDevR in 2011, Craig spent 15 successful years in sales and marketing for several multi-national organizations including Bayer Corporation and Beckman Coulter. He’s held positions in both the Life Science and the Clinical Diagnostic divisions. Before joining the sales side of the business, he worked in the lab as an organic chemist with Elli Lilly and Company. Craig received his M.B.A. from the University of Pittsburgh and his B.S in Organic Chemistry from the University of Michigan, Ann Arbor. |
